Indeed, Fra-1 was rapidly shown capable of stimulating several genes important in cancer through binding to AP-1/TRE and/or CRE motifs [12] in studies where the authors took advantage of AP-1-binding sites localized relatively close (kb range) to the genes' transcriptional start sites (TSS). Here, JUND is linked to cancer.